Therapeutics Acquisition Corp.

announcedU=S+W/3W=S@11.50
RACASEC EDGARCIK: 0001811764|Therapeutic Acquisition Holdings LLC•Precision Oncology

Capital Structure & Economics

Trust Size$100,000,000
Unit Price$10.00
Warrant Coverage1/3
Sponsor Promote20%

Implied Equity Architecture

Capital Allocation Baseline

Trust (100.0%)

Implied Dilution Drag

33% Warrant Inclusion
Public Trust Allocation$100,000,000
Sponsor At-Risk CapitalN/A
Total Underwriting DiscountN/A
Trust Per Unit (Implied)$10.00
Sponsor Promote Allocation20%
Deal Lifecycle
IPO PricedJun 15, 2020
SearchingTarget Pending
Maturation Wall
N/A

Announced Target / M&A

  • Target CompanyPOINT Biopharma Inc.
  • SectorPrecision Oncology
  • Announced Deal Size$585,000,000

Board & Officers

  • Joe A. McCannCEO
  • RA Capital Management, L.P.Officer

Advanced Structuring Terms

Target SectorsPrecision Oncology

Syndicate & Advisors

Interactive Deal Modeling

Base financial constraints (Trust Size, Warrants, Promote) are pre-loaded into the calculation engines. Proceed to model implied dilution and advisory friction limits.

Dilution Cash Friction